Lucia Dora Notarangelo
Overview
Explore the profile of Lucia Dora Notarangelo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
1050
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Migliavacca M, Barzaghi F, Fossati C, Rancoita P, Gabaldo M, Dionisio F, et al.
Nat Med
. 2024 Feb;
30(2):488-497.
PMID: 38355973
Adenosine deaminase (ADA) deficiency leads to severe combined immunodeficiency (SCID). Previous clinical trials showed that autologous CD34 cell gene therapy (GT) following busulfan reduced-intensity conditioning is a promising therapeutic approach...
2.
Fratini E, Migliavacca M, Barzaghi F, Fossati C, Giannelli S, Monti I, et al.
Front Immunol
. 2023 Jul;
14:1187959.
PMID: 37435083
Hemophagocytic inflammatory syndrome (HIS) is a rare form of secondary hemophagocytic lymphohistiocytosis caused by an impaired equilibrium between natural killer and cytotoxic T-cell activity, evolving in hypercytokinemia and multiorgan failure....
3.
Zanon E, Pasca S, Sottilotta G, Molinari A, Ferretti A, Di Gregorio P, et al.
Blood Transfus
. 2022 Dec;
21(4):350-355.
PMID: 36580025
Background: Congenital factor XIII (FXIII) deficiency is a rare coagulation disorder characterized by muscular or mucocutaneous bleeding with life-threatening intracranial hemorrhages (ICHs), especially in cases with severe disease. The best...
4.
Fioredda F, Onofrillo D, Farruggia P, Barone A, Veltroni M, Notarangelo L, et al.
Pediatr Blood Cancer
. 2022 Mar;
69(6):e29599.
PMID: 35253359
Neutropenia refers to a group of diseases characterized by a reduction in neutrophil levels below the recommended age threshold. The present study aimed to review the diagnosis and management of...
5.
Munaretto V, Voi V, Palazzi G, Notarangelo L, Corti P, Baretta V, et al.
Br J Haematol
. 2021 May;
194(5):851-854.
PMID: 34036565
No abstract available.
6.
Guarina A, Marinoni M, Lassandro G, Saracco P, Perrotta S, Facchini E, et al.
Turk J Haematol
. 2021 May;
38(3):175-180.
PMID: 34002598
Objective: The association between celiac disease (CD) and immune thrombocytopenia (ITP) is still uncertain. The aim of this study was to characterize the coexistence of these two diseases in Italian...
7.
Casale M, Forni G, Cassinerio E, Pasquali D, Origa R, Serra M, et al.
Haematologica
. 2021 Jan;
107(2):467-477.
PMID: 33406815
Transfusion-dependent patients typically develop iron-induced cardiomyopathy, liver disease, and endocrine complications. We aimed to estimate the incidence of endocrine disorders in transfusiondependent thalassemia (TDT) patients during long-term iron-chelation therapy with...
8.
Lassandro G, Palmieri V, Barone A, Farruggia P, Giona F, Licciardello M, et al.
Pediatr Blood Cancer
. 2020 Dec;
68(3):e28840.
PMID: 33274837
Background: Fatigue is an important clinical and psychological aspect for a significant number of children affected by immune thrombocytopenia (ITP). To date, few studies have explored fatigue and its relationship...
9.
Giordano P, Lassandro G, Barone A, Cesaro S, Fotzi I, Giona F, et al.
Front Med (Lausanne)
. 2020 Mar;
7:66.
PMID: 32181255
The thrombopoietin receptor agonist eltrombopag has been shown to be safe and effective for children with chronic immune thrombocytopenia (ITP). The aim of the present study was to characterize eltrombopag...
10.
Russo G, Guardabasso V, Romano F, Corti P, Samperi P, Condorelli A, et al.
Ann Hematol
. 2020 Jan;
99(3):413-420.
PMID: 31965272
Oral ferrous salts are standard treatment for children with iron deficiency anemia (IDA). The objective of our study was to monitor oral iron therapy in children, aged 3 months-12 years,...